MIMEDX Group, Inc.
corporate_fare Company Profile
MIMEDX Group, Inc. (NASDAQ:MDXG) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 21 items for MDXG at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-28, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 14 rated 8 or above. Recent SEC coverage for MDXG spans 8-K, 10-Q, 424B3, S-4.
Recent high-impact activity:
- MiMedx Q3 Sales Fall 45% to $62M; Adjusted EBITDA Turns Positive, 2026 Outlook Set at $250-260M
- MiMedx Q3 Loss Narrows to $8.7M; Credit Covenant Breach Waived, Wound Sales Down 71%
- MiMedx Posts $8.68M Q3 Loss as Wound-Care Pressure Persists
- MiMedx Lands $25M Patent License Deal With Wound Care Rival
- FTC Second Request Delays MiMedx's $350M Sanara Acquisition
Financial Snapshot
Short Interest & Short Volume
9.08 days to coverFINRA reported short interest of 9,264,529 shares in MDXG as of the October 15, 2026 settlement, a 1.0% decrease from the prior period — about 9.1 days to cover at its recent average daily volume. On October 28, 2026, 35.6% of MDXG volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.